1 follower
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together wi... Read more
Industries
Headquarters
Employees
Links
Joshua Stahl
Pendulum
4 followers
Stemline Therapeutics
3 followers
Sutro Biopharma
2 followers
Arbutus Biopharma
2 followers
Inari
1 follower
Fortis Life Sciences
1 follower
Capsida Biotherapeutics
1 follower
Zageno
1 follower
Matica Biotechnology
1 follower
Lineage Cell Therapeutics
1 follower
Eikon Therapeutics
1 follower
Discover companies